Morgan Stanley’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-675
Closed -$2.54K 8216
2024
Q3
$2.54K Sell
675
-717
-52% -$2.69K ﹤0.01% 7083
2024
Q2
$13.3K Buy
1,392
+407
+41% +$3.89K ﹤0.01% 6579
2024
Q1
$74.5K Sell
985
-111
-10% -$8.4K ﹤0.01% 6092
2023
Q4
$195K Buy
1,096
+966
+743% +$172K ﹤0.01% 5958
2023
Q3
$91.5K Buy
130
+31
+31% +$21.8K ﹤0.01% 5933
2023
Q2
$455K Buy
99
+8
+9% +$36.8K ﹤0.01% 5261
2023
Q1
$242K Hold
91
﹤0.01% 5624
2022
Q4
$239K Buy
91
+7
+8% +$18.4K ﹤0.01% 5590
2022
Q3
$331K Sell
84
-15
-15% -$59.1K ﹤0.01% 5477
2022
Q2
$258K Buy
99
+3
+3% +$7.82K ﹤0.01% 5770
2022
Q1
$309K Buy
96
+7
+8% +$22.5K ﹤0.01% 5677
2021
Q4
$555K Buy
89
+54
+154% +$337K ﹤0.01% 5482
2021
Q3
$325K Sell
35
-216
-86% -$2.01M ﹤0.01% 5740
2021
Q2
$2.54M Buy
251
+249
+12,450% +$2.52M ﹤0.01% 4453
2021
Q1
$43K Buy
2
+1
+100% +$21.5K ﹤0.01% 6418
2020
Q4
$6K Sell
1
-2
-67% -$12K ﹤0.01% 6752
2020
Q3
$9K Hold
3
﹤0.01% 6313
2020
Q2
$10K Buy
+3
New +$10K ﹤0.01% 6164
2019
Q1
Hold
0
6744
2018
Q4
Hold
0
6770
2018
Q3
Hold
0
-$1K 6837
2018
Q2
Hold
0
6618
2018
Q1
Hold
0
6722
2017
Q4
Hold
0
-$1K 6677
2017
Q3
Hold
0
-$1K 6475
2017
Q2
Hold
0
-$9K 6529
2017
Q1
Hold
0
-$1K 6250
2016
Q4
Hold
0
-$3K 6470
2016
Q3
Hold
0
-$3K 6331
2016
Q2
Hold
0
-$9K 6317
2016
Q1
Hold
0
-$9K 6159
2015
Q4
Hold
0
-$15K 6269
2015
Q3
Hold
0
-$17K 6135
2015
Q2
Hold
0
-$35K 6177
2015
Q1
Hold
0
-$2K 5907
2014
Q4
Hold
0
-$5K 6444
2014
Q3
Hold
0
-$8K 6332
2014
Q2
Hold
0
-$27K 6233
2014
Q1
Hold
0
-$39K 5888
2013
Q4
Hold
0
5681